The goal of the Genetic Counseling (GC) Shared Resource is to facilitate clinical, behavioral, and basic science research involving cancer genetics and inherited susceptibility. The work of the GC Resource contributes substantially to transdisciplinary cancer investigations and research collaborations by integrating basic science discoveries (gene discovery) with population research (high-risk syndrome characterization) and clinical trials (genetic testing for diagnosis of potential subjects) to further Huntsman Cancer Institute's (HCI) individualized oncology goals. Specifically, the GC Shared Resource provides 1) study consultation with investigators;2) recruitment of high-risk individuals into studies and registries so data and biospecimens are readily available for clinical and basic researchers;3) expertise necessary for cancer syndrome diagnosis, genetic counseling, and genetic testing so investigators can incorporate genetic variation into study design and interpretation;and 4) education for researchers about the role of genetic susceptibility in cancer. Currently, the GC Shared Resource assists with studies to define the genetics and phenotype of hereditary cancer syndromes, identify new high- and low-penetrant cancer predisposition genes, evaluate the psychosocial implications of genetic diagnoses, and evaluate screening and management approaches for high-risk patients. Over the past five years, the GC Shared Resource has developed into a fully integrated Shared Resource, providing genetic counseling services to all Cancer Center investigators. The GC Shared Resource is quintessential to the high-risk cancer diagnosis, prevention, and treatment missions of the Cancer Center and to the longstanding strength and emphasis on cancer genetics and inherited susceptibility at the University of Utah and HCI. The GC Shared Resource has expanded to meet the growing needs of the Cancer Center. Wendy Kohlman, MS, genetic counselor, is the Resource Director;the Shared Resource team also includes three other licensed genetic counselors who deal with high-risk and syndromic persons with cancer and their families. The GC Shared Resource is a Cancer Center-managed facility with supervision from HCI Directors. A Faculty Advisory Committee meets regularly to review goals, quality of service, strategies, and needs for the Resource;a survey assesses user satisfaction. Funds are requested from the CCSG to cover 20 percent of the proposed GC Shared Resource budget ($48,772).

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Utah
Salt Lake City
United States
Zip Code
Albright, Frederick; Stephenson, Robert A; Agarwal, Neeraj et al. (2015) Prostate cancer risk prediction based on complete prostate cancer family history. Prostate 75:390-8
Eiring, A M; Page, B D G; Kraft, I L et al. (2015) Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia. Leukemia 29:586-97
Lerman, Daniel M; Monument, Michael J; McIlvaine, Elizabeth et al. (2015) Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group. Pediatr Blood Cancer 62:759-65
Quackenbush, John F; Cassidy, Pamela B; Pfeffer, Lawrence M et al. (2014) Isolation of circulating microRNAs from microvesicles found in human plasma. Methods Mol Biol 1102:641-53
Clark, Kathleen A; Graves, Barbara J (2014) Dual views of SRF: a genomic exposure. Genes Dev 28:926-8
Oakley, Gretchen M; Curtin, Karen; Layfield, Lester et al. (2014) Increased melanoma risk in individuals with papillary thyroid carcinoma. JAMA Otolaryngol Head Neck Surg 140:423-7
Zhang, Rui; Yang, Jiyuan; Sima, Monika et al. (2014) Sequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates. Proc Natl Acad Sci U S A 111:12181-6
Smith, M A; Hoffman, L M; Beckerle, M C (2014) LIM proteins in actin cytoskeleton mechanoresponse. Trends Cell Biol 24:575-83
Van Vranken, Jonathan G; Bricker, Daniel K; Dephoure, Noah et al. (2014) SDHAF4 promotes mitochondrial succinate dehydrogenase activity and prevents neurodegeneration. Cell Metab 20:241-52
Gibson, Summer B; Figueroa, Karla P; Bromberg, Mark B et al. (2014) Familial clustering of ALS in a population-based resource. Neurology 82:17-22

Showing the most recent 10 out of 805 publications